LYELLyell Immunopharma Inc. Common Stock
15.53USD-1.46%Mkt Cap: 380.56M $P/E: —3d ago
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap380.56M $
Enterprise Value218.65M $
Revenue (TTM)27.00K $
Gross Profit27.00K $
Net Income (TTM)-274.45M $
Revenue/Share0.0010 USD
Last Price15.53 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.43
PEG—
EV/EBITDA-1.21
EV/Revenue8098.15
P/S13931.63
P/B1.54
EPS (TTM)-12.31
EPS (Forward)-6.32
52W Range
10.4915% of range45.00
52W High45.00 USD
52W Low10.49 USD
Profitability
Gross Margin100.00%
Oper. Margin-1183425.00%
EBITDA Margin0.00%
Profit Margin-762355.56%
ROE-110.57%
ROA-80.71%
Growth
Revenue Growth-50.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-150.02M $
CapEx (TTM)780.00K $
FCF Margin-269663.44%
FCF Yield-19.13%
Net Debt-157.50M $
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.21
Current Ratio5.36
Quick Ratio5.12
Book Value/Sh9.993 USD
Cash/Share8.329 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 2, 2025
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.88 USD
Upside (mean)+143.9%
Target Range12.00 USD – 49.00 USD
$12.00+143.9% to mean$49.00
# Analysts8
Ownership
Shares Out.24.51M
Float12.15M
Insiders37.28%
Institutions54.20%
Short Interest
Short Ratio7.2d
Short % Float5.87%
Short % Out.5.03%
Shares Short1.23M
Short (prev mo.)1.22M
Technical
SMA 5013.64 (+13.8%)
SMA 20020.43 (-24.0%)
Beta-0.07
S&P 52W Chg18.16%
Avg Vol (30d)155.13K
Avg Vol (10d)156.37K
Technical Indicators
RSI (14)60.0
MACD0.3106
MACD Signal0.1042
MACD Hist.+0.2064
BB Upper15.61 USD
BB Middle13.79 USD
BB Lower11.97 USD
BB Width26.40%
ATR (14)1.120 USD
Vol Ratio (20d)0.63x